Global Scleroderma Diagnostics and Therapeutics Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 15, 2021--
The “Scleroderma Diagnostics and Therapeutics - Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Scleroderma Diagnostics and Therapeutics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 10.3% over the period 2020-2027.
Localized, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Systemic segment is readjusted to a revised 11% CAGR for the next 7-year period.
The U.S. Market is Estimated at $598.9 Million, While China is Forecast to Grow at 9.6% CAGR
The Scleroderma Diagnostics and Therapeutics market in the U.S. is estimated at US$598.9 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$692.8 Million by the year 2027 trailing a CAGR of 9.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.4% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
Select Competitors (Total 42 Featured):
- Actelion Pharmaceuticals Ltd.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Corbus Pharmaceuticals Holdings, Inc.
- Cumberland Pharmaceuticals, Inc.
- Cytori Therapeutics, Inc.
- Gilead Sciences, Inc.
- Pfizer, Inc.
- Sanofi SA
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/26swpx
View source version on businesswire.com:https://www.businesswire.com/news/home/20210415005751/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 04/15/2021 11:10 AM/DISC: 04/15/2021 11:11 AM